Last reviewed · How we verify
NCT07144644
2311 TURGOR Study -Surgical Efficiency and Postoperative Corneal Clarity With Near Physiologic vs High IOP Settings
trial testing Adjusting intraocular pressure (IOP) settings in Intraocular Pressure in 81 participants. Completed in 6 August 2025.
6 August 2025
Quick facts
| Lead sponsor | Research Insight LLC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 81 |
| Start date | 26 July 2024 |
| Primary completion | 6 August 2025 |
| Estimated completion | 6 August 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Adjusting intraocular pressure (IOP) settings
Conditions studied
- Intraocular Pressure — all drugs for Intraocular Pressure →
Sponsor
Research Insight LLC — full company profile →
Who can join
18 and older, any sex, with Intraocular Pressure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to investigate whether adjusting intraocular pressure (IOP) settings to near physiologic levels during cataract surgery could potentially lead to better surgical outcomes, particularly in terms of corneal clarity in the post-operative period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07144644
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intraocular Pressure
Currently open trials in the same condition.
- NCT07274176 — The Effect of Graded Forced Expiration on Intraocular Pressure · NA · recruiting
- NCT06666751 — Anterior Segment Optical Coherence Tomography Microstent Positioning · active not recruiting
- NCT06016712 — The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes · NA · recruiting
- NCT05753137 — Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial · NA · recruiting
- NCT05850936 — Effect of IOP Lowering on Progressive HM · NA · active not recruiting
Other Research Insight LLC trials
Trials by the same sponsor.
- NCT07276802 — The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) · Phase 4 · not yet recruiting
- NCT06482164 — The THINK Study Incidence of Neurotrophic Keratopathy) · NA · completed
- NCT06482177 — The COAT Trial: Cequa's Onset of Action Trial · Phase 4 · completed
- NCT05346172 — The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction · completed
- NCT05322148 — Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07144644 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Research Insight LLC
- Last refreshed: 27 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07144644.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing